Half Year 2023 Universal Biosensors Inc Earnings Call Transcript
Thank you for standing by, and welcome to the Universal Biosensors investor webinar and Q&A following recent results announced by the company. Please note that the presentation being used today has been lodged with the ASX. (Operator Instructions) And also, please note that this session is being recorded and can be heard afterwards.
On behalf of Universal Biosensors today we have CEO, John Charman. John, I'll hand it over to you. Please go ahead.
Thanks, Matt, and good morning, everyone. Thanks for your attendance and for your ongoing interest. So this is a an update as to our H1 2023 performance, and it's worthy of having a recap. Early in 2020, UBI had one product in market. In the last 2.5 years, we've developed another nine products and we have 10 revenue generating assets delivering millions of test strips to thousands of customers around the world.
As we sit here today, we have $16.6 million of cash reserves. Our R&D rebate is expected to be another $4.5 million, and we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |